By Sarina Isaacs
Shares of Inotiv lost ground after the company priced a public offering of 6 million shares.
The stock was recently down 14.8% to $4.73 in premarket trading. As of Tuesday's close, it had gained about 60% over the past year.
The pharmaceutical company on Wednesday said it is offering 6 million common shares priced at $4.25 apiece, for a total of $25.5 million. Inotiv has also granted the underwriter a 30-day option to buy up to another 900,000 shares
The West Lafayette, Ind., company said net proceeds will go toward working capital, capital expenditures and other general corporate purposes.
The offering is expected to close Dec. 19.
Write to Sarina Isaacs at sarina.isaacs@wsj.com
(END) Dow Jones Newswires
December 18, 2024 09:24 ET (14:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。